Associations among nucleated cell, CD34+ cell and colony-forming cell contents in cord blood units obtained through a standardized banking process

被引:42
作者
Aroviita, P
Teramo, K
Westman, P
Hiilesmaa, V
Kekomäki, R
机构
[1] Finnish Red Cross Blood Transfus Serv, Cord Blood Bank, FIN-00310 Helsinki, Finland
[2] Univ Helsinki Hosp, Dept Obstet & Gynecol, Helsinki, Finland
关键词
CD34(+) cell; colony-forming unit; cord blood banking; nucleated cell; standardization;
D O I
10.1046/j.1423-0410.2003.00276.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives Nucleated cell content is one of the main components used when evaluating cord blood (CB) units for clinical use. However, other indicators of the haematopoietic potential of a CB unit, such as CD34(+) cell and colony-forming cell (CFU-TOT) content, have also been investigated. The aim of this study was to determine whether the CD34(+) cell content could be used in selecting CB collections for banking. Materials and Methods The collection data, as well as cellular contents of 588 CB collections obtained using a standardized CB banking process, were analysed. Results Altogether, 526 CB units from the 588 collections accepted for processing were included in international search registries. The volume collected was, as expected, 69 ml (range 28-116 ml). The correlation between total CD34(+) cell and CFU-TOT (n = 88) content in the CB collection was higher (r = 0.87) than the correlation between the total nucleated cell and CFU-TOT content (r = 0.69, both P < 0.0001). The correlations of pre- and postvolume reduction values of the total nucleated cell and CD34(+) cell numbers were highly significant (r = 0.96, P < 0.0001, both). The total CFU-TOT content of the CB collection correlated significantly with the total CD34(+) cell content of the CB unit before cryopreservation (but after volume reduction) (r = 0.89, P < 0.0001). Conclusions CD34(+) cell content predicts the haematopoietic potential of a CB unit better than nucleated cell content. Accordingly, the CD34(+) cell content of CB could be used to select CB for banking purposes and for transplantation.
引用
收藏
页码:219 / 227
页数:9
相关论文
共 31 条
[11]   Current status of umbilical cord blood hematopoietic stem cell transplantation [J].
Gluckman, E .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (11) :1197-1205
[12]  
Hakenberg P, 1998, BONE MARROW TRANSPL, V22, pS17
[13]  
HARRIS DT, 1994, BONE MARROW TRANSPL, V13, P135
[14]   Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients [J].
Kurtzberg, J ;
Laughlin, M ;
Graham, ML ;
Smith, C ;
Olson, JF ;
Halperin, EC ;
Ciocci, G ;
Carrier, C ;
Stevens, CE ;
Rubinstein, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (03) :157-166
[15]  
Lazzari L, 1996, J Hematother, V5, P117, DOI 10.1089/scd.1.1996.5.117
[16]   The number of nucleated cells reflects: the hematopoietic content of umbilical cord blood for transplantation [J].
Lim, FTH ;
van Beckhoven, JM ;
Brand, A ;
Kluin-Nelemans, JC ;
Hermans, JMH ;
Willemze, R ;
Kanhai, HHH ;
Falkenburg, JHF .
BONE MARROW TRANSPLANTATION, 1999, 24 (09) :965-970
[17]   DONOR MARROW PROGENITORS (CFU-MIX, BFU-E AND CFU-GM) AND HEMATOPOIETIC ENGRAFTMENT FOLLOWING HLA MATCHED SIBLING BONE-MARROW TRANSPLANTATION [J].
MA, DDF ;
VARGA, DE ;
BIGGS, JC .
LEUKEMIA RESEARCH, 1987, 11 (02) :141-147
[18]   Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity [J].
Migliaccio, AR ;
Adamson, JW ;
Stevens, CE ;
Dobrila, NL ;
Carrier, CM ;
Rubinstein, P .
BLOOD, 2000, 96 (08) :2717-2722
[19]  
*NETCORD FAHCT, 2000, INT STAND CORD BLOOD
[20]  
Querol S, 1998, BONE MARROW TRANSPL, V22, pS3